annb0t
Top 20
Mesoblast Limited
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Philip R. Krause, M.D. has joined its Board of Directors. Dr. Krause was for the past decade Deputy Director, Office of Vaccines Research and Review (OVRR) at the US Food and Drug Administration (FDA)âs Center for Biologics Evaluation and Research (CBER). Dr. Krause is currently Chair of the W...
>>> Read more: Philip R. Krause, M.D., Former FDA Deputy Chief for Vaccines, Joins Mesoblast Board
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Philip R. Krause, M.D. has joined its Board of Directors. Dr. Krause was for the past decade Deputy Director, Office of Vaccines Research and Review (OVRR) at the US Food and Drug Administration (FDA)âs Center for Biologics Evaluation and Research (CBER). Dr. Krause is currently Chair of the W...
>>> Read more: Philip R. Krause, M.D., Former FDA Deputy Chief for Vaccines, Joins Mesoblast Board
